Lumbar Interbody Fusion using Low-dose of Recombinant Human Bone Morphogenetic Protein-2 (rh-BMP2); Minimum 1-year Follow-up Results at A Single Institute

Objective The authors evaluate clinical results of the lumbar interbody fusion surgery using low-dose of recombinant human bone morphogenetic protein type 2(rhBMP-2) to assess the safety and efficacy of rhBMP-2. Methods 199 patients who underwent lumbar interbody fusion surgery including posterior l...

Full description

Bibliographic Details
Main Authors: Sang-soo Choi, Wo-Jung Lim, Min-Ki Lee, Kyeong-Sik Ryu
Format: Article
Language:English
Published: Korean Minimally Invasive Spine Surgery Society 2021-04-01
Series:Journal of Minimally Invasive Spine Surgery and Technique
Subjects:
Online Access:http://www.jmisst.org/upload/pdf/jmisst-2021-00094.pdf